You are now leaving the
BioTherapeutics website

Baxter is not responsible for the privacy policy, the content or the accuracy of any web site accessed through a link on the biotherapeutics.com site. A link to other web sites does not constitute an endorsement by Baxter of the linked site, its products or services.

cache cache cache cache
Select Region:
Text Size:
Glossary  |  Site Map  |  Contact Us  |  News Room
BioTherapeutics Baxter wordmark link to corporate website

OUR COMMITMENT

BioTherapeutics is committed to developing therapies with the aim of saving and sustaining lives. Our aim is to provide the highest quality products and programs that advance patient care globally and enable the achievement of outcomes through innovation, science, and technology.

The BioTherapeutics' team specializes in three key therapeutic areas: immunoglobulins, pulmonology, and critical care therapies. BioTherapeutics' immunoglobulin therapies treat primary immunodeficiencies associated with defects in humoral immunity or a lack of antibody production. BioTherapeutics also produces antibody-replacement therapies to bolster the immune system of people with secondary immunodeficiencies and recurrent infections. Immunoglobulin therapies also include treatments for ITP in patients with low platelet counts.
Read More [+]

NEWS ROOM

Baxter and the Jeffrey Modell Foundation Support Efforts to Increase Awareness of Primary Immunodeficiency During the Annual World Day of Immunology

print | email

Deerfield, IL, April 29, 2010 - Today, Baxter International, Inc. and the Jeffrey Modell Foundation (JMF) are supporting expanded global activities in conjunction with the 6th annual World Day of Immunology.
Read More [+]

Cincinnati Children's Opens Jeffrey Modell Foundation Diagnostic Center for Primary Immunodeficiencies

print | email

CINCINNATI – Cincinnati Children’s Hospital Medical Center today dedicates the opening of a Jeffrey Modell Foundation (JMF) Diagnostic Center for Primary Immunodeficiencies, one of only 55 of its kind in the world and only 31 in the United States.
Read More [+]

Push to raise awareness of Primary Immunodeficiencies as prestigious US Foundation supports London diagnostic centre

print | email

London, October 27th 2009 - Today, the Royal Free and Great Ormond Street Hospitals announced the opening of a Jeffrey Modell Foundation Diagnostic Centre for Primary Immunodeficiencies in London.
Read More [+]

World Day Immunology

FEATURED PRODUCTS

Gammagard Liquid

Ready-to-use 10% sterile, liquid preparation
Read More [+]

Aralast NP

Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
Read More [+]